Search

everythinglearnresearchcommunity

for

Search:↓

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

High levels of HSP70 and IL-15 are linked to more severe alopecia areata.

Researchers found a new mutation in the HR gene causing hair loss and skin bumps in a Pakistani family.

Ixekizumab is safe for long-term use with low rates of major heart-related events.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Hirsutism greatly affects mental health and quality of life, especially in young women.

The gel effectively reduced folliculitis symptoms and was safe to use.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Nemolizumab improved both severe atopic dermatitis and alopecia areata in one patient.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Patients and doctors often agree on the severity of eyebrow and eyelash hair loss in severe alopecia areata.

Testosterone needs to be converted to DHT to reduce stress response in male rats.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

Nearly 20% of recovered COVID-19 patients have skin issues, with hair loss and rashes being common.

The study found that PCOS affects about 6.5-6.8% of women in both urban and rural areas of Telangana, India, and highlighted the importance of lifestyle changes for management.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

A woman with Lupus Vasculitis improved after treatment with steroids and other medications.

Apremilast shows promise for several skin conditions but needs more research.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Hirsutism is common among Iraqi women, often without a known cause, but family history is significant.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Ostrich antibodies are a promising, cost-effective treatment for various skin diseases and conditions.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Secukinumab for psoriasis may cause hair loss.